Zdrowie i gospodarka · 14/05/1998

FDA Proposes Registration and Listing Requirements for Human Cellular and Tissue-Based Products

The FDA is proposing a unified registration and listing program for manufacturers of human cellular and tissue-based products, requiring them to register with the agency and list their products, in an effort to streamline regulations and improve oversight.